Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

BIRMINGHAM, Ala. , Oct. 22, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes").

Encompass Health Issues Notice for Partial Redemption of Its 5.75% Senior Notes Due 2025

Astrana Health Inc

Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both Encompass Health (EHC) and Astrana Health, Inc. (ASTH). But which of these two stocks offers value investors a better bang for their buck right now?

EHC vs. ASTH: Which Stock Is the Better Value Option?

Encompass Health (EHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Encompass Health (EHC) Earnings Expected to Grow: Should You Buy?

Encompass Health (EHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Encompass Health (EHC) Beat Estimates Again in Its Next Earnings Report?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Encompass Health (EHC) is a Strong Value Stock

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?

BIRMINGHAM, Ala. , Oct. 17, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on Jan. 15, 2025, to holders of record on Jan. 2, 2025.

Encompass Health Declares Dividend on Common Stock

Amazon

Broadcom

Churchill Downs

General Electric

NVIDIA

Option Care Health

Parsons Corp

Skechers U.S.A.

Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.

The Best Growth Stocks to Buy

BIRMINGHAM, Ala. , Oct. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.

Encompass Health Announces Date of 2024 Third Quarter Earnings Call

Encompass Health (EHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Encompass Health (EHC) Upgraded to Buy: Here's What You Should Know

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Encompass Health (EHC) Stock Undervalued Right Now?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Encompass Health (EHC) is a Top-Ranked Momentum Stock: Should You Buy?

EHC remains well-poised for growth on the back of improved revenues, an extensive rehabilitation hospital network and sufficient cash-generating abilities.

Compelling Reasons to Hold on to Encompass Health Stock Right Now

This new facility is part of EHC's continued strategy to meet the rising demand for rehabilitative services.

Encompass Health Opens 9th Hospital in SC: More in the Pipeline?

The 39-bed inpatient rehabilitation hospital is Encompass Health's 165th hospital. BIRMINGHAM, Ala.

Encompass Health Rehabilitation Hospital of Fort Mill Now Open in South Carolina

Here's Why Encompass Health (EHC) is a Strong Momentum Stock

To meet the increasing demand for its services, EHC is expected to continue adding beds.

Encompass Health Stock Rises 39.4% YTD: Should You Buy Now?

Encompass Health (EHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Encompass Health (EHC) Rating Upgrade to Buy

Encompass Health's (EHC) Q2 results reflect improved net patient revenue per discharge, partly offset by higher costs. It currently estimates 2024 adjusted EPS within $3.97-$4.22, up from the earlier view of $3.86-$4.11.

Encompass Health (EHC) Stock Down 6% Despite Q2 Earnings Beat

Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Encompass Health (EHC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Encompass Health (EHC) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $0.95 per share a year ago.

Encompass Health (EHC) Q2 Earnings Beat Estimates

Increases full-year guidance BIRMINGHAM, Ala. , Aug. 5, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the second quarter ended June 30, 2024.

Encompass Health reports results for second quarter 2024

Addus HomeCare

Quest Diagnostics

DaVita

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.

4 Stocks to Watch From a Challenging Outpatient Home Health Industry

Evaluate the expected performance of Encompass Health (EHC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

News for Encompass Health Stock (EHC)